Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants
Clinical trial NCT05134337 · COMPLETED
Trial details
- NCT number
- NCT05134337
- Sponsor
- Loxo Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-12
- Primary completion
- 2020-10-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.